Gsk (GSK) EBITDA Margin (2009 - 2026)
Gsk (GSK) posted EBITDA Margin of 36.13% for the quarter ended Mar 31, 2026, down 4.31 percentage points from 40.43% a year earlier but up 8.61 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, EBITDA Margin at Gsk was 28.29%, up 2.04 percentage points year-over-year; for the year ended Dec 31, 2025, it was 35.85%, up 13.52 percentage points from the prior year.
- Annual EBITDA Margin shows a five-year change of +15.28 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's EBITDA Margin was 22.33% in the year ended Dec 31, 2024 (-13.30 pp), 35.63% in the year ended Dec 31, 2023 (+2.15 pp), 33.48% in the year ended Dec 31, 2022 (+2.33 pp) and 31.15% in the year ended Dec 31, 2021 (+10.58 pp).
- Quarterly EBITDA Margin has run from a low of 13.06% in the quarter ended Dec 31, 2021 to a high of 40.43% in the quarter ended Mar 31, 2025 over five years.
- On a year-over-year basis, EBITDA Margin increased in two of the last four quarters, with an average year-over-year change of +3.55 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was the quarter ended Mar 31, 2025, with a gain of 12.74 percentage points; the weakest was the quarter ended Mar 31, 2024, with a drop of 11.47 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 39.16% |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 36.13% |
| Dec 31, 2025 | 27.52% |
| Mar 31, 2025 | 40.43% |
| Dec 31, 2024 | 19.00% |
| Mar 31, 2024 | 27.69% |
| Dec 31, 2023 | 21.75% |
| Mar 31, 2023 | 39.16% |
| Dec 31, 2022 | 25.42% |
| Mar 31, 2022 | 37.71% |
| Dec 31, 2021 | 13.06% |
| Mar 31, 2021 | 30.48% |
| Dec 31, 2020 | 23.06% |
| Mar 31, 2020 | 24.29% |
| Dec 31, 2019 | 27.26% |
| Sep 30, 2019 | 28.34% |
| Mar 31, 2019 | 34.08% |
| Dec 31, 2018 | 26.20% |
| Mar 31, 2018 | 23.79% |
| Dec 31, 2017 | 18.27% |
| Mar 31, 2017 | 27.68% |
API Access
Gsk EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();